MCKESSON CORP. $157

MCKESSON CORP. $157 (New York symbol MCK; Aggressive Growth Portfolio, Consumer sector; Shares outstanding: 229.0 million; Market cap: $36.0 billion; Price-to-sales ratio: 0.2; Dividend yield: 0.7%; TSINetwork Rating: Above Average; www.mckesson .com) is buying the Rexall chain of 470 drug stores in Canada for $2.2 billion. The company expects to complete the purchase by the end of 2016. McKesson already distributes prescription drugs and other products to Rexall, and this familiarity helps cut the risk of an unpleasant surprise. Excluding integration charges and currency exchange rates, the company expects the new operations will add to its earnings in the first year. McKesson is a hold.

A professional investment analyst for more than 30 years, Pat has developed a stock-selection technique that has proven reliable in both bull and bear markets. His proprietary ValuVesting System™ focuses on stocks that provide exceptional quality at relatively low prices. Many savvy investors and industry leaders consider it the most powerful stock-picking method ever created.